Light beam attack on tough pancreatic tumors shows promise
NCT ID NCT05919238
First seen Feb 15, 2026 · Last updated May 19, 2026 · Updated 21 times
Summary
This early-stage trial tests a new light-activated treatment for people with advanced pancreatic cancer that cannot be removed by surgery. The therapy uses a special drug and a tiny light fiber placed in the tumor's blood vessels to destroy cancer cells. The main goals are to check safety and find the best light dose, with hopes of shrinking tumors and possibly making them operable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED UNRESECTABLE PANCREATIC ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
Contact
-
University of California Irvine
RECRUITINGIrvine, California, 92697, United States
Contact
Conditions
Explore the condition pages connected to this study.